These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 12930431

  • 1. Urodynamic verification of an overactive bladder is not a prerequisite for antimuscarinic treatment response.
    Malone-Lee J, Henshaw DJ, Cummings K.
    BJU Int; 2003 Sep; 92(4):415-7. PubMed ID: 12930431
    [Abstract] [Full Text] [Related]

  • 2. In women with urinary incontinence how necessary is cystometry?
    Saleem A.
    J Pak Med Assoc; 2010 May; 60(5):356-9. PubMed ID: 20527606
    [Abstract] [Full Text] [Related]

  • 3. Cizolirtine citrate is safe and effective for treating urinary incontinence secondary to overactive bladder: a phase 2 proof-of-concept study.
    Zát'ura F, Vsetica J, Abadías M, Pavlík I, Schraml P, Brod'ák M, Villoria J, Sust M, E-4018/CL50 Study Group.
    Eur Urol; 2010 Jan; 57(1):145-52. PubMed ID: 19446951
    [Abstract] [Full Text] [Related]

  • 4. Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo-controlled trial.
    Homma Y, Paick JS, Lee JG, Kawabe K, Japanese and Korean Tolterodine Study Group.
    BJU Int; 2003 Nov; 92(7):741-7. PubMed ID: 14616458
    [Abstract] [Full Text] [Related]

  • 5. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
    Halaska M, Ralph G, Wiedemann A, Primus G, Ballering-Brühl B, Höfner K, Jonas U.
    World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500
    [Abstract] [Full Text] [Related]

  • 6. Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women.
    Goode PS, Burgio KL, Locher JL, Umlauf MG, Lloyd LK, Roth DL.
    J Am Geriatr Soc; 2002 May; 50(5):808-16. PubMed ID: 12028165
    [Abstract] [Full Text] [Related]

  • 7. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
    Malone-Lee JG, Al-Buheissi S.
    BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
    [Abstract] [Full Text] [Related]

  • 8. Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder.
    Abrams P, Freeman R, Anderström C, Mattiasson A.
    Br J Urol; 1998 Jun; 81(6):801-10. PubMed ID: 9666761
    [Abstract] [Full Text] [Related]

  • 9. Urodynamic variables cannot be used to classify the severity of detrusor instability.
    Wagg A, Bayliss M, Ingham NJ, Arnold K, Malone-Lee J.
    Br J Urol; 1998 Oct; 82(4):499-502. PubMed ID: 9806177
    [Abstract] [Full Text] [Related]

  • 10. Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial.
    Malone-Lee J, Shaffu B, Anand C, Powell C.
    J Urol; 2001 May; 165(5):1452-6. PubMed ID: 11342895
    [Abstract] [Full Text] [Related]

  • 11. Case series data to encourage randomized trials of bladder retraining compared to antimuscarinic agents.
    Ghei M, Miller R, Malone-Lee J.
    J Urol; 2006 Apr; 175(4):1411-5; discussion 1415-6. PubMed ID: 16516010
    [Abstract] [Full Text] [Related]

  • 12. Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial.
    Diokno AC, Appell RA, Sand PK, Dmochowski RR, Gburek BM, Klimberg IW, Kell SH, OPERA Study Group.
    Mayo Clin Proc; 2003 Jun; 78(6):687-95. PubMed ID: 12934777
    [Abstract] [Full Text] [Related]

  • 13. Overactive bladder syndrome: what is the role of evidence of detrusor overactivity in the cystometric study?
    Vecchioli-Scaldazza C, Grinta R.
    Minerva Urol Nefrol; 2010 Dec; 62(4):355-61. PubMed ID: 20944536
    [Abstract] [Full Text] [Related]

  • 14. A phase 2, randomized, double-blind, efficacy and safety study of oxybutynin vaginal ring for alleviation of overactive bladder symptoms in women.
    Gittelman M, Weiss H, Seidman L.
    J Urol; 2014 Apr; 191(4):1014-21. PubMed ID: 24231837
    [Abstract] [Full Text] [Related]

  • 15. Fesoterodine treatment of pediatric patients with neurogenic detrusor overactivity: A 24-week, randomized, open-label, phase 3 study.
    Kitta T, Darekar A, Malhotra B, Shahin MH, Jones P, Lindsay M, Mallen S, Nieto A, Crook TJ.
    J Pediatr Urol; 2023 Apr; 19(2):175.e1-175.e10. PubMed ID: 36504158
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the efficacy of tolterodine and oxybutynin in different urodynamic severity grades of idiopathic detrusor overactivity.
    Giannitsas K, Perimenis P, Athanasopoulos A, Gyftopoulos K, Nikiforidis G, Barbalias G.
    Eur Urol; 2004 Dec; 46(6):776-82; discussion 782-3. PubMed ID: 15548447
    [Abstract] [Full Text] [Related]

  • 17. [Diagnosis of overactive bladder influenced by methods of clinical assessment--micturition diary vs. urodynamics].
    Skorupski P, Tomaszewski J, Adamiak A, Jankiewicz K, Rechberger T.
    Ginekol Pol; 2003 Sep; 74(9):1018-22. PubMed ID: 14674162
    [Abstract] [Full Text] [Related]

  • 18. Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment.
    Palleschi G, Pastore AL, Stocchi F, Bova G, Inghilleri M, Sigala S, Carbone A.
    Clin Neuropharmacol; 2006 Sep; 29(4):220-9. PubMed ID: 16855424
    [Abstract] [Full Text] [Related]

  • 19. Optimum Dose of Once-Daily Oxybutynin Patch in Japanese Patients with Overactive Bladder: A Randomized Double-Blind Trial Versus Placebo.
    Yamaguchi O, Uchida E, Higo N, Minami H, Kobayashi S, Sato H, Oxybutynin Patch Study Group.
    Low Urin Tract Symptoms; 2016 Sep; 8(3):150-8. PubMed ID: 27619779
    [Abstract] [Full Text] [Related]

  • 20. Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings.
    Hyman MJ, Groutz A, Blaivas JG.
    J Urol; 2001 Aug; 166(2):550-2; discussion 553. PubMed ID: 11458066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.